» Articles » PMID: 26859561

A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species

Overview
Journal PLoS One
Date 2016 Feb 10
PMID 26859561
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There is a real medical need of new diagnostic tools for the early recognition of invasive Candida infections. We exploited a rather simple and rapid redox methodology to construct a bispecific monoclonal antibody (bsmAb) that combines a monoclonal antibody (mAb) directed against 1,3-β-D-glucan, a well-known, pan-fungal diagnostic biomarker, with a mAb recognizing MP65, a major immunogenic mannoprotein secreted by C.albicans and other Candida species. The bsmAb (MP65/bglu mAb) was successfully produced and purified at high yields and proved to bind and reveal simultaneously, with high sensitivity, the β-glucan and MP65 antigens in both purified and native forms. The MP65/bglu mAb is the first bispecific antibody generated against a fungal microorganism and may prove useful for the concurrent detection of different and clinically significant Candida biomarkers in patient sera.

Citing Articles

SUR7 deletion in s impacts extracellular vesicle features and delivery of virulence factors.

McKenna J, Garcia-Ceron D, Bleackley M, Yu L, Bulone V, Anderson M J Extracell Biol. 2024; 2(5):e82.

PMID: 38938278 PMC: 11080841. DOI: 10.1002/jex2.82.


The Role of B-Cells and Antibodies against Vaccine Antigens in Invasive Candidiasis.

Shukla M, Chandley P, Rohatgi S Vaccines (Basel). 2021; 9(10).

PMID: 34696267 PMC: 8540628. DOI: 10.3390/vaccines9101159.


The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches.

Weiss Z, Leon A, Koo S J Fungi (Basel). 2021; 7(2).

PMID: 33572400 PMC: 7916227. DOI: 10.3390/jof7020127.


Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Gabaldon T FEMS Microbiol Rev. 2019; 43(5):517-547.

PMID: 31158289 PMC: 8038933. DOI: 10.1093/femsre/fuz015.


A detergent-based procedure for the preparation of IgG-like bispecific antibodies in high yield.

Gupta J, Hoque M, Zaman M, Khan R, Saleemuddin M Sci Rep. 2016; 6:39198.

PMID: 27982091 PMC: 5159798. DOI: 10.1038/srep39198.

References
1.
Wang G, Marquardt R, Xiao H, Zhang Z . Development of a 96-well enzyme-linked solid-phase assay for beta-glucanase and xylanase. J Agric Food Chem. 1999; 47(3):1262-7. DOI: 10.1021/jf980702w. View

2.
DiGiandomenico A, Keller A, Gao C, Rainey G, Warrener P, Camara M . A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med. 2014; 6(262):262ra155. DOI: 10.1126/scitranslmed.3009655. View

3.
Dmitriev D, Massino Y, Segal O, Smirnova M, Kolyaskina G, Pavlova E . The comparison of the ability of monoclonal antibodies directed to different proteins (human IgG, human myoglobin and HRP) and bispecific antibodies derived thereof to bind antigens immobilized on a surface of a solid phase. Clin Chim Acta. 2001; 309(1):57-71. DOI: 10.1016/s0009-8981(01)00531-9. View

4.
Hellwig S, van Spriel A, Schellekens J, Mooi F, van de Winkel J . Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun. 2001; 69(8):4846-50. PMC: 98573. DOI: 10.1128/IAI.69.8.4846-4850.2001. View

5.
Lindorfer M, Nardin A, Foley P, Solga M, Bankovich A, Martin E . Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J Immunol. 2001; 167(4):2240-9. DOI: 10.4049/jimmunol.167.4.2240. View